Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Assets (2016 - 2025)

Historic Assets for Aspen Aerogels (ASPN) over the last 13 years, with Q3 2025 value amounting to $491.4 million.

  • Aspen Aerogels' Assets fell 3720.89% to $491.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $491.4 million, marking a year-over-year decrease of 3720.89%. This contributed to the annual value of $895.1 million for FY2024, which is 2732.33% up from last year.
  • Per Aspen Aerogels' latest filing, its Assets stood at $491.4 million for Q3 2025, which was down 3720.89% from $525.1 million recorded in Q2 2025.
  • In the past 5 years, Aspen Aerogels' Assets ranged from a high of $895.1 million in Q4 2024 and a low of $99.9 million during Q1 2021
  • Its 5-year average for Assets is $506.9 million, with a median of $555.0 million in 2025.
  • In the last 5 years, Aspen Aerogels' Assets soared by 25168.18% in 2022 and then tumbled by 3720.89% in 2025.
  • Quarter analysis of 5 years shows Aspen Aerogels' Assets stood at $183.0 million in 2021, then surged by 251.68% to $643.4 million in 2022, then increased by 9.27% to $703.0 million in 2023, then grew by 27.32% to $895.1 million in 2024, then plummeted by 45.1% to $491.4 million in 2025.
  • Its Assets was $491.4 million in Q3 2025, compared to $525.1 million in Q2 2025 and $555.0 million in Q1 2025.